{"name":"Cellid Co., Ltd.","slug":"cellid-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AdCLD-CoV19-1 OMI","genericName":"AdCLD-CoV19-1 OMI","slug":"adcld-cov19-1-omi","indication":"COVID-19 prevention (Omicron variant)","status":"phase_3"}]}],"pipeline":[{"name":"AdCLD-CoV19-1 OMI","genericName":"AdCLD-CoV19-1 OMI","slug":"adcld-cov19-1-omi","phase":"phase_3","mechanism":"AdCLD-CoV19-1 OMI is an adenoviral vector-based vaccine designed to elicit immune responses against Omicron variant SARS-CoV-2 antigens.","indications":["COVID-19 prevention (Omicron variant)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPRjd6d2d4Vnl0dlB3Rk1lbXN5NWxqaFljLTlrdGVZX2UtRjBBMnBMdzJwdkV5RUJQalRoNWxFbE5Sek5FZHpuazFhaEliQk5EZzVJQm5UbVhZdEF1bTF6LUtLcWhDRHVuaVJhNVFLNlM5OWdIVV9zX2lfMDEtWG55em1ldGkxNmNQR1Z2Nlo5M0ZfSFk?oc=5","date":"2026-04-08","type":"trial","source":"openPR.com","summary":"Human Papillomavirus Associated Cancer Clinical Trial - openPR.com","headline":"Human Papillomavirus Associated Cancer Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNclM2VFVoUzFjeUtJRkJGOXlTWWtTMk42UHR2Y3RGbWdfZ2pqVlh2cHI0MW9qcF81R3pFd1VVSG1wLW9ydFktZUkzdVVzeWV1TVJGN1F0MTd2UDV5SlBvYmpkT2RFRTZxVzFtSkRNdDd2TjBrMmJPTnpVUGtpRHVhb0p5X25DaThYcDFHSEFqWUkycFBxZjdOOTZMN25lVnY0X01iQXNyRGMtYUEtTFVnZ1JvMzFQYVRPY3ZOdmFRYw?oc=5","date":"2025-02-06","type":"pipeline","source":"PR Newswire","summary":"Cellid Raises $13 Million to Advance AR Glasses Display Development - PR Newswire","headline":"Cellid Raises $13 Million to Advance AR Glasses Display Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"PR Newswire","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - PR Newswire","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}